Normal view MARC view ISBD view

Anti-diabetic effect of sprouted trigonella foenum- graecum l. seed solid dosage form in low-dose streptozotocin induced diabetic rats

By: Mishra, Ashwini Kumar.
Contributor(s): Sahoo, Pravat Kumar.
Publisher: Bangalore Association of Pharmaceutical Teachers of India (APTI) 2022Edition: Vol.56(4), Oct-Dec.Description: 1156-1163p.Subject(s): PHARMACEUTICSOnline resources: Click here In: Indian journal of pharmaceutical education and researchSummary: Background: Trigonella foenum-graecum L (Fenugreek) is an annual herb, mainly cultivated for its seed as well as for its sprouts. Pharmacological investigations reported anti-bacterial, anti-diabetic, anti-cancer, anti-diarrheal, anti-hypercholesteremic, and anti- inflammatory activities of Trigonella foenum-graecum L. Aim: The purpose of this study was to accentuate on formulation of granules and investigate the effect of germinated Trigonella foenum-graecum L. (TFG) granules in Diabetes mellitus (DM) rats induced by streptozotocin as fenugreek retains hypoglycemic property. Materials and Methods: Granules of germinated TFG powder were arranged by means of several excipients comprising diverse amounts of super disintegrants by (wet) granulation method and proceed for the solid dosage form evaluation. Further, in-vivo study was performed in STZ induced DM Wister rats for four weeks. TFG granules 1600mg/kg and Glibenclamide 0.45 mg/kg (as a positive control for comparison) were orally administrated and evaluate the diabetics in rats. Results: All evaluation parameter are correct: as in standard tablet. The STZ (Streptozotocin) induced rats the treatment with the Drug (Glibenclamide) and TFG granules significantly lowered the blood plasma glucose levels by 36% (mean ± SD glucose 120 ± 0.6 mg/dL ( p < 0.001)) and 38% (mean ± SD glucose 114 ± 0.4 mg/dL; p < 0.001) respectively after 4 weeks of treatment when compared to T2DM (Type 2 Diabetes mellitus) rats. Conclusion: Experimental studies had shown that bioactive compounds found in Trigonella Foenum graceum herb have potential to cure diabetes especially due to the presence of unique chemical constituent including trigonelline, galactomannan and amino acid 4-hydroxy isoleucine. These findings suggested that TFG granules may be an alternative medicine for the management of DM.
Tags from this library: No tags from this library for this title. Log in to add tags.
    average rating: 0.0 (0 votes)
Item type Current location Call number Status Date due Barcode Item holds
Articles Abstract Database Articles Abstract Database School of Pharmacy
Archieval Section
Not for loan 2023-0117
Total holds: 0

Background:
Trigonella foenum-graecum L (Fenugreek) is an annual herb, mainly
cultivated for its seed as well as for its sprouts. Pharmacological investigations reported
anti-bacterial, anti-diabetic, anti-cancer, anti-diarrheal, anti-hypercholesteremic, and anti-
inflammatory activities of
Trigonella foenum-graecum L. Aim: The purpose of this study
was to accentuate on formulation of granules and investigate the effect of germinated
Trigonella foenum-graecum L. (TFG) granules in Diabetes mellitus (DM) rats induced
by streptozotocin as fenugreek retains hypoglycemic property. Materials and Methods:
Granules of germinated TFG powder were arranged by means of several excipients
comprising diverse amounts of super disintegrants by (wet) granulation method and
proceed for the solid dosage form evaluation. Further,
in-vivo study was performed in
STZ induced DM Wister rats for four weeks. TFG granules 1600mg/kg and Glibenclamide
0.45 mg/kg (as a positive control for comparison) were orally administrated and evaluate
the diabetics in rats. Results: All evaluation parameter are correct: as in standard tablet.
The STZ (Streptozotocin) induced rats the treatment with the Drug (Glibenclamide) and
TFG granules significantly lowered the blood plasma glucose levels by 36% (mean ± SD
glucose 120 ± 0.6 mg/dL (
p < 0.001)) and 38% (mean ± SD glucose 114 ± 0.4 mg/dL;
p < 0.001) respectively after 4 weeks of treatment when compared to T2DM (Type
2 Diabetes mellitus) rats. Conclusion: Experimental studies had shown that bioactive
compounds found in
Trigonella Foenum graceum herb have potential to cure diabetes
especially due to the presence of unique chemical constituent including trigonelline,
galactomannan and amino acid 4-hydroxy isoleucine. These findings suggested that TFG
granules may be an alternative medicine for the management of DM.

There are no comments for this item.

Log in to your account to post a comment.

Click on an image to view it in the image viewer

Unique Visitors hit counter Total Page Views free counter
Implemented and Maintained by AIKTC-KRRC (Central Library).
For any Suggestions/Query Contact to library or Email: librarian@aiktc.ac.in | Ph:+91 22 27481247
Website/OPAC best viewed in Mozilla Browser in 1366X768 Resolution.

Powered by Koha